U.S. markets open in 21 minutes

Nevro Corp. (NVRO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
158.18+1.44 (+0.92%)
At close: 4:00PM EDT
158.18 0.00 (0.00%)
Pre-Market: 08:38AM EDT

Nevro Corp.

1800 Bridge Parkway
Redwood City, CA 94065
United States
650 251 0005
http://www.nevro.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees843

Key Executives

NameTitlePayExercisedYear Born
Mr. D. Keith GrossmanChairman, CEO & Pres1.4MN/A1960
Mr. Roderick H. MacLeodChief Financial Officer546.9kN/A1967
Mr. Kashif RashidGen. Counsel, Corp. Sec. & Chief Compliance Officer605.57kN/A1974
Mr. Andrew H. GalliganExec. Officer776.95k11.81M1956
Ms. Niamh Louise PellegriniChief Commercial Officer701.21k328.45k1967
Mr. Patrick SchmitzVP of OperationsN/AN/A1960
Ms. Julie D. DeweyVP of Investor Relations & Corp. CommunicationsN/AN/A1961
Mr. Michael Collier CarterVP of Global SalesN/AN/A1972
Mr. Jon R. ShearVP of Corp. Devel.N/AN/AN/A
Ms. Lori M. CianoChief HR OfficerN/AN/A1963
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. In addition, the company provides HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Corporate Governance

Nevro Corp.’s ISS Governance QualityScore as of June 1, 2021 is 5. The pillar scores are Audit: 4; Board: 5; Shareholder Rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.